October 24th 2024
Nina Vadiei, PharmD, BCPP, a clinical associate professor at UT Austin and a clinical pharmacy specialist in psychiatry at San Antonio State Hospital, discusses her career as a psychiatric pharmacist.
FDA announces ongoing cardiovascular safety review of olmesartan
July 15th 2010FDA has announced that the agency is currently evaluating whether the use of the angiotensin II receptor blocker (ARB) olmesartan (Benicar, Daiichi Sankyo; also sold in combination with hydrocholorothiazide as Benicar HCT) was associated with increased cardiovascular mortality.
Overuse of antibiotics spurs vicious cycle
June 23rd 2010Patients whose doctors over-prescribe antibiotics may develop drug resistance that can last up to a year, putting them and others at risk when more serious treatment is needed, according to a study published in May in the British Medical Journal.
Community pharmacists to gather for annual NCPA convention
June 23rd 2010The National Community Pharmacists Association (NCPA) will present the latest in pharmacy education, case studies, and real-world, business-oriented information for the independent community-pharmacy industry at its 112th Annual Convention and Trade Exposition taking place at the Pennsylvania Convention Center in Philadelphia Oct. 23 to 27.
Counterfeit Tamiflu sold on Internet puts consumers at risk
June 23rd 2010FDA notified consumers and healthcare professionals that a product represented as "Generic Tamiflu" being sold on the Internet does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.